Cargando…

Serum TAG Analysis Differentiates Between Genetic and Obesity-Associated NAFLD

Detalles Bibliográficos
Autores principales:	Mashek, Douglas G., Greenberg, Andrew S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968431/ https://www.ncbi.nlm.nih.gov/pubmed/24357693 http://dx.doi.org/10.2337/db13-1500

Ejemplares similares

Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD
por: Mashek, Douglas G.
Publicado: (2020)

MD2 AMP(K)s up the link between lipid accumulation and inflammation in NAFLD
por: Heldens, Anneleen, et al.
Publicado: (2022)

The VASP Road to NAFLD: A Macrophage Detour
por: Lastra, Guido, et al.
Publicado: (2015)

Differential Outcomes and Clinical Challenges of NAFLD With Extreme Obesity
por: Arnouk, Joud, et al.
Publicado: (2020)

The Association between Pediatric NAFLD and Common Genetic Variants
por: Umano, Giuseppina Rosaria, et al.
Publicado: (2017)

The use of ultrasound in clinical setting for children affected by NAFLD: is it safe and accurate?
por: Nobili, Valerio, et al.
Publicado: (2011)

NAFLD Phenotype in Patients With V-ATPase Proton Pump Assembly Defects
por: Jansen, Jos C., et al.
Publicado: (2018)

Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD
por: Tauriainen, Milla-Maria, et al.
Publicado: (2018)

Why Hepatic CYP2E1-Elevation by Itself Is Insufficient for Inciting NAFLD/NASH: Inferences from Two Genetic Knockout Mouse Models
por: Correia, Maria Almira, et al.
Publicado: (2020)

The correlation between NAFLD and serum uric acid to serum creatinine ratio
por: Choi, Jangwon, et al.
Publicado: (2023)

The relationship between obesity and prostate cancer: from genetics to disease treatment and prevention
por: Lughezzani, Giovanni
Publicado: (2012)

Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals
por: Malhi, Harmeet, et al.
Publicado: (2023)

Correction: The Correlation Between NAFLD and Serum Uric Acid to Serum Creatinine Ratio
por: Choi, Jangwon, et al.
Publicado: (2023)

Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study
por: Wang, Qinqiu, et al.
Publicado: (2021)

“Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”
por: Hanna, David J., et al.
Publicado: (2021)

Study of serum visfatin and blood glucose and lipid metabolism, nafld in simple obese children
por: Li, Rui-zhen, et al.
Publicado: (2015)

Obesity and the brain: a possible genetic link
por: Bertram, Lars, et al.
Publicado: (2010)

New insight of obesity-associated NAFLD: Dysregulated “crosstalk” between multi-organ and the liver?
por: Wang, Ya-Di, et al.
Publicado: (2022)

Developmental Programming of NAFLD by Parental Obesity
por: Thompson, Michael D.
Publicado: (2020)

Genetics Is of the Essence to Face NAFLD
por: Meroni, Marica, et al.
Publicado: (2021)

Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
por: Garcia, Daniel, et al.
Publicado: (2019)

Irx3, a new leader on obesity genetics
por: Schneeberger, Marc
Publicado: (2018)

A SUMO-Phospho tag team for wrestling with potassium channel gating
por: Mandikian, Danielle, et al.
Publicado: (2011)

pHluorin-tagged TRPV1 shines light on capsaicin tachyphylaxis
por: Agosti, Francina, et al.
Publicado: (2019)

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
por: Enooku, Kenichiro, et al.
Publicado: (2019)

Genetic Ablation of MiR-22 Fosters Diet-Induced Obesity and NAFLD Development
por: Gjorgjieva, Monika, et al.
Publicado: (2020)

Genetics of obesity in consanguineous populations – A road map to provide novel insights in the molecular basis and management of obesity
por: Kapoor, Nitin, et al.
Publicado: (2019)

Intestinal Barrier and Permeability in Health, Obesity and NAFLD
por: Portincasa, Piero, et al.
Publicado: (2021)

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
por: Henao-Mejia, Jorge, et al.
Publicado: (2012)

Non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD in type 2 diabetic patients
por: Zhang, Ziyin, et al.
Publicado: (2022)

Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults
por: Bae, Ji Cheol, et al.
Publicado: (2012)

Nutrition and Genetics in NAFLD: The Perfect Binomium
por: Meroni, Marica, et al.
Publicado: (2020)

Comment on Tauriainen et al.: Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD
por: Plat, Jogchum, et al.
Publicado: (2018)

Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD
por: Ezaz, Ghideon, et al.
Publicado: (2020)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
por: Li, Yifang, et al.
Publicado: (2021)

Is fat mass & obesity-associated (FTO) gene master regulator of obesity ?
por: Mittal, Balraj, et al.
Publicado: (2016)

Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort
por: Wang, Jun, et al.
Publicado: (2021)

Genetic Factors Associated with Response to Vitamin E Treatment in NAFLD
por: Civelek, Mehtap, et al.
Publicado: (2022)

Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD
por: Bilson, Josh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o8uieckeqg8fav30j2u4m5q4j9